Loading...
Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia
Long-acting pasireotide is an effective treatment option for acromegaly, but it is associated with hyperglycemia, which could impact its use in patients with diabetes. We present a case of a 53-year-old man with acromegaly and type 2 diabetes mellitus (glycated hemoglobin (HbA(1c)): 7.5%), who refus...
Na minha lista:
| Udgivet i: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Bioscientifica Ltd
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5445444/ https://ncbi.nlm.nih.gov/pubmed/28567297 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-17-0003 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|